Literature DB >> 1178902

Comparative gastric antisecretory and antiulcer effects of prostaglandin E1 and its methyl ester in animals.

E Z Dajani, D R Driskill, R G Bianchi, P W Collins.   

Abstract

The influence of methyl esterification of the carboxyl group of PGE1 on the gastric antisecretory and antiulcer activities were studied. The gastric antisecretory effects of PGE1 free acid and PGE1 methyl ester (PGE1ME) were studied in the Heidenhain pouch dog. Secretion was stimulated with constant intravenous infusion of histamine dihydrochloride. When a steady-state plateau of gastric secretion had been reached, the prostaglandins were administered either by a single intravenous bolus (10.0 mug/kg) or by continuous infusion (1.0 mug/kg/min). PGE1ME was found to be slightly more potent and longer-acting than PFE1 when administered by a single i.v. bolus. PGE1ME was also shown to be more potent than PGE1 when infused intravenously for a two-hour period. PGE1ME caused a significant alteration in gastric juice concentration of hydrogen and sodium ions in an inverse relationship. Potassium and chloride concentration were not altered from pre-existing steady-state values following administration of either form of prostaglandin. Similarly, PGE1ME was also found to possess significantly greater antiulcer activity in the rat forced-exertion ulcer test. These findings support the hypothesis that methyl esterification of the prostaglandin molecule will increase some of the biological actions of PGE1 through inhibition of metabolic beta-oxidation of the carboxylic side chain.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1178902     DOI: 10.1016/0090-6980(75)90040-4

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  8 in total

1.  Expression of gastric antisecretory and prostaglandin E receptor binding activity of misoprostol by misoprostol free acid.

Authors:  B S Tsai; L K Kessler; J Stolzenbach; G Schoenhard; R F Bauer
Journal:  Dig Dis Sci       Date:  1991-05       Impact factor: 3.199

2.  Exogenous prostaglandins and gastric secretion in the cat.

Authors:  R Baker; B M Jaffe; J D Reed; B Shaw; C W Venables
Journal:  J Physiol       Date:  1978-05       Impact factor: 5.182

3.  Stimulated gastric prostaglandin output, and the effect of inhibition of prostaglandin synthetase, in the conscious cat.

Authors:  R Baker; B M Jaffe; B Shaw; C W Venables
Journal:  J Physiol       Date:  1981-08       Impact factor: 5.182

4.  Effect of misoprostol on histamine-stimulated acid secretion and cyclic AMP formation in isolated canine parietal cells.

Authors:  B S Tsai; L K Kessler; G M Butchko; R F Bauer
Journal:  Dig Dis Sci       Date:  1987-09       Impact factor: 3.199

Review 5.  Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease.

Authors:  J P Monk; S P Clissold
Journal:  Drugs       Date:  1987-01       Impact factor: 9.546

6.  Gastric antisecretory effects of E prostaglandins in Rhesus monkeys.

Authors:  E Z Dajani; D A Callison; R G Bianchi; D R Driskill
Journal:  Am J Dig Dis       Date:  1976-12

7.  SC-29333: a potent inhibitor of canin gastric secretion.

Authors:  E Z Dajani; D R Driskill; R G Bianchi; P W Collins; R Pappo
Journal:  Am J Dig Dis       Date:  1976-12

8.  Endogenous prostaglandins in peptic ulcer disease.

Authors:  R Baker; B M Jaffe; C W Venables
Journal:  Gut       Date:  1979-05       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.